Clinical Trial Update: 6-year Antibody Check After Third Vaccination Against Japanese Encephalitis [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting antibody levels assessed six years after the third vaccination against Japanese encephalitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Japanese Encephalitis Vaccine (Japanese Encephalitis vaccine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Post Other Specified Vaccination Encephalitis | Phase 4 | Status: COMPLETED